Champions Sports, Inc. Changes Name to Champions Biotechnology, Inc.
January 22 2007 - 9:33AM
PR Newswire (US)
ARLINGTON, Va., Jan. 22 /PRNewswire-FirstCall/ -- Champions Sports,
Inc. (OTC:CSBR) (BULLETIN BOARD: CSBR) , announced today the change
of its name to Champions Biotechnology, Inc. The Company sold its
Champions service mark and concept for sports themed restaurants to
Marriott International, Inc. in 1997 and has since been seeking a
new business direction. The change of name is intended reflect the
decision of the Company to focus on biotechnology as its new
business approach. Recently, Dr. David Sidransky and Dr. Manuel
Hidalgo, both with established credentials in the field of
biotechnology, have become major investors with the Company. The
management and owners of the Company intend to use their expertise
to build a biotechnology company and have decided to seek ventures
in that field. The change of name to Champions Biotechnology, Inc.
has been filed with the State of Delaware. This press release
contains "forward-looking statements" (within the meaning of the
Private Securities Litigation Act of 1995) that inherently involve
risk and uncertainties. The Company generally uses words such as
"believe," "may," "could," "will," "intend," "expect,"
"anticipate," "plan," and similar expressions to identify
forward-looking statements. One should not place undue reliance on
these forward-looking statements. The Company's actual results
could differ materially from those anticipated in the
forward-looking statements for many unforeseen factors, which may
include, but are not limited to, changes in general economic
conditions, the ongoing threat of terrorism, ability to have access
to financing sources on reasonable terms and other risks that are
described in this document. Although the Company believes the
expectations reflected in the forward-looking statements are
reasonable, they relate only to events as of the date on which the
statements are made, and the Company's future results, levels of
activity, performance or achievements may not meet these
expectations. The Company does not intend to update any of the
forward-looking statements after the date of this press release to
conform these statements to actual results or to changes in the
Company's expectations, except as required by law. CONTACT: James
Martell of Champions Biotechnology, Inc. (703)-526-0400.
DATASOURCE: Champions Biotechnology, Inc. CONTACT: James Martell of
Champions Biotechnology, Inc., +1-703-526-0400
Copyright